Fact Pattern 19-1
Cardio, Inc., makes and sells Drawdown, the most prescribed name-brand heart medication. Emitate Corporation has the potential to make a generic version of the same drug.

-Refer to Fact Pattern 19-1.Cardio pays Emitate not to sell its product.This is

Question

Fact Pattern 19-1 
Cardio, Inc., makes and sells Drawdown, the most prescribed name-brand heart medication. Emitate Corporation has the potential to make a generic version of the same drug.

-Refer to Fact Pattern 19-1.Cardio pays Emitate not to sell its product.This is

Quizplus · Accepted Answer

Paying a competitor not to sell a product is considered a form of price-fixing agreement, as it restricts competition and maintains higher prices for the name-brand drug.